On 14 May the Lung Cancer Policy Network will be joining the Institute for Social Policy Development to host a policy roundtable Warsaw, Poland and online. At the event, leading figures will discuss the status of lung cancer in Central and Eastern Europe (CEE) and generate tangible actions for policy change.
The event will bring together key stakeholders to explore how lung cancer care can be improved across the region. Speakers will include leading clinicians, researchers and policymakers, who will discuss the importance of LDCT screening and its potential to improve outcomes, while also providing consensus-driven insights on how to implement optimal screening programmes. EU representatives will also be present to discuss the role of screening as a priority in Europe’s Beating Cancer Plan.
Speakers will include:
- Penilla Gunther, EU Cancer Mission board member, Sweden
- Henryka Krzywonos, Member of Polish Parliament
- Mariusz Adamek, Medical University of Silesia and Medical University of Gdańsk, Poland
- Kristina Krpina, University Hospital Centre Zagreb, Croatia
- Bartosz Kwiatek, Polsat News journalist, Poland
Online attendees will have the opportunity to hear keynote speeches and roundtable discussions about the status of screening implementation across the region, the steps needed to ensure LDCT screening is optimally implemented, and examples of success that can be applied globally.
Around 70,000 people in the CEE region are diagnosed with lung cancer every year. The region faces unique challenges including high smoking rates, rising prevalence amongst women, and a unique reimbursement and funding model. However, by making optimal screening available, it is estimated that 38,000 lives could be saved annually.
Currently, three CEE countries – Poland, Croatia and the Czech Republic – have national implementation programmes. Speakers at the event will showcase experiences and insights from these programmes with the aim of helping other governments prioritise the wide-scale implementation of lung cancer screening and realise population-level impact and improved treatment outcomes.
Recent news
Blog
Lung cancer: the looming economic crisis governments can’t ignore
Lung cancer carries a heavy cost – not only for the people diagnosed, but for health systems and economies alike.
Blog
Beyond lung cancer: how LDCT screening could reshape early detection
Health systems are under growing strain. The challenge is no longer simply how to treat illness, but how to detect it earlier and manage it more efficiently.
News
Insights from the I-ELCAP 3rd Annual AGILEᴰˣᴿˣ meeting
In March, the Network attended the International Early Lung Cancer Action Program 3rd Annual AGILEᴰˣᴿˣ meeting in Gdańsk, Poland.